Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia

L Lin, L Lu, W Cao, T Li - Emerging microbes & infections, 2020 - Taylor & Francis
ABSTRACT Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact …

Immune responses and pathogenesis of SARS‐CoV‐2 during an outbreak in Iran: comparison with SARS and MERS

M Rokni, V Ghasemi, Z Tavakoli - Reviews in medical virology, 2020 - Wiley Online Library
The beginning of 2020 has seen the emergence of COVID‐19, an outbreak caused by a
novel coronavirus, SARS‐CoV‐2, an important pathogen for humans. There is an urgent …

Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection

Y Liang, ML Wang, CS Chien, AA Yarmishyn… - Frontiers in …, 2020 - frontiersin.org
A sudden outbreak of COVID-19 caused by a novel coronavirus, SARS-CoV-2, in Wuhan,
China in December 2019 quickly grew into a global pandemic, putting at risk not only the …

[PDF][PDF] Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic

E Prompetchara, C Ketloy, T Palaga - Asian Pacific journal of …, 2020 - apjai-journal.org
As the world is witnessing the epidemic of COVID-19, a disease caused by a novel
coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path …

Host immune response and immunobiology of human SARS-CoV-2 infection

S Kumar, R Nyodu, VK Maurya, SK Saxena - Coronavirus Disease 2019 …, 2020 - Springer
One of the most serious viral outbreaks of the decade, infecting humans, originated from the
city of Wuhan, China, by the end of December 2019, has left the world shaken up. It is the …

[HTML][HTML] COVID-19: Unanswered questions on immune response and pathogenesis

E Maggi, GW Canonica, L Moretta - Journal of Allergy and Clinical …, 2020 - Elsevier
The novel coronavirus disease 2019 has rapidly increased in pandemic scale since it first
appeared in Wuhan, China, in December 2019. In these troubled days the scientific …

Overview of the pathogenesis of COVID‑19

C Li, Q He, H Qian, J Liu - … and Therapeutic Medicine, 2021 - spandidos-publications.com
At present, the pathogenesis of the novel coronavirus disease 2019 (COVID‑19) has not
been fully elucidated. Clinical and experimental findings from studies investigating COVID …

A review of SARS-CoV2: compared with SARS-CoV and MERS-CoV

H Zhou, J Yang, C Zhou, B Chen, H Fang… - Frontiers in …, 2021 - frontiersin.org
The outbreak of coronavirus disease 2019 (COVID-19) has been spreading rapidly in China
and the Chinese government took a series of policies to control the epidemic. Studies found …

The comparative immunological characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 coronavirus infections

Y Zhang, B Li, B Ning - Frontiers in Immunology, 2020 - frontiersin.org
Immune dysfunction and aberrant cytokine storms often lead to rapid exacerbation of the
disease during late infection stages in SARS-CoV and MERS-CoV patients. However, the …

Immune response, inflammation, and the clinical spectrum of COVID-19

LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …